AETHLON MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value
AETHLON MEDICAL, INC. (AEMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value of $2.19 per share for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-10.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue · last filed 2026-06-10
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average intrinsic value for the quarter ending 2024-06-30 was $0.50.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average intrinsic value for fiscal 2026 was $2.19, a 23.43% decline from fiscal 2025.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average intrinsic value for fiscal 2025 was $2.86, a 70.24% increase from fiscal 2024.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average intrinsic value for fiscal 2024 was $1.68, a 342.11% increase from fiscal 2023.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average intrinsic value for fiscal 2023 was $0.38, a 73.97% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value 12 month |
|---|---|---|---|
| 2026-03-31 | $2.19 10-K · filed 2026-06-10 | ||
| 2025-03-31 | $2.86 10-K · filed 2025-06-26 | ||
| 2024-09-30 | $0.47 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $0.50 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | $1.68 10-K · filed 2024-06-27 | ||
| 2023-03-31 | $0.38 10-K · filed 2023-06-28 | ||
| 2022-03-31 | $1.46 10-K · filed 2022-06-28 | ||
| 2019-03-31 | $1.52 10-K · filed 2020-06-25 | ||
| 2018-03-31 | -$0.95 10-K · filed 2019-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |